natgillin/translations-raw huggingface dataset:
Korea Heungjin Trading Company
Poduzeće Korea Taesong Trading Company
Daedong Credit Bank (DCB)
Banka Daedong Credit Bank (DCB)
Korea Daesong Bank
Banka Korea Daesong Bank
Korea Pugang Trading Corporation
Korporacija Korea Pugang Trading Corporation
Korea Taesong Trading Company
Poduzeće Korea Taesong Trading Company
Kangbong Trading Corporation
Korporacija Kangbong Trading Corporation
Korea Kumsan Trading Corporation
Korporacija Korea Daesong Trading Corporation
Koryo Bank
Banka Koryo Bank
Commission Regulation (EU) 2017/1510
Uredba Komisije (EU) 2017/1510
of 30 August 2017
оd 30. kolovoza 2017.
amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances
o izmjeni dodataka Prilogu XVII. Uredbi (EZ) br. 1907/2006 Europskog parlamenta i Vijeća o registraciji, evaluaciji, autorizaciji i ograničavanju kemikalija (REACH) u pogledu tvari CMR
Having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC [1], and in particular Article 68(2) thereof,
uzimajući u obzir Uredbu (EZ) br. 1907/2006 Europskog parlamenta i Vijeća od 18. prosinca 2006. o registraciji, evaluaciji, autorizaciji i ograničavanju kemikalija (REACH), osnivanju Europske agencije za kemikalije te o izmjeni Direktive 1999/45/EZ i stavljanju izvan snage Uredbe Vijeća (EEZ) br. 793/93 i Uredbe Komisije (EZ) br. 1488/94 kao i Direktive Vijeća 76/769/EEZ i direktiva Komisije 91/155/EEZ, 93/67/EEZ, 93/105/EZ i 2000/21/EZ [1], a osobito njezin članak 68. stavak 2.,
Entries 28, 29 and 30 of Annex XVII to Regulation (EC) No 1907/2006 prohibit the placing on the market or use for supply to the general public of substances that are classified as carcinogenic, mutagenic or reproductive toxicant (CMR), category 1A or 1B, and of mixtures containing such substances in specified concentrations.
Unosima 28., 29. i 30. iz Priloga XVII. Uredbi (EZ) br. 1907/2006 zabranjuju se stavljanje na tržište i uporaba u slobodnoj ponudi tvari koje su razvrstane kao karcinogene, mutagene ili reproduktivno toksične (CMR) kategorije 1 A ili 1B te smjesa koje sadržavaju takve tvari u određenim koncentracijama.
The substances concerned are listed in Appendices 1 to 6 to that Annex.
Predmetne tvari navedene su u dodacima od 1. do 6. tom Prilogu.
Substances are classified as CMR in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council [2] and are listed in Part 3 of Annex VI to that Regulation.
Tvari su razvrstane kao CMR u skladu s Uredbom (EZ) br. 1272/2008 Europskog parlamenta i Vijeća [2] te su navedene u dijelu 3. Priloga VI. toj Uredbi.
Since Appendices 1 to 6 to Annex XVII to Regulation (EC) No 1907/2006 were last updated to reflect new classifications of substances as CMR under Regulation (EC) No 1272/2008, Part 3 of Annex VI to the latter has been amended by Commission Regulations (EU) No 605/2014 [3], (EU) 2015/1221 [4] and (EU) 2016/1179 [5].
Budući da su dodaci od 1. do 6. Prilogu XVII. Uredbi (EZ) br. 1907/2006 posljednji put ažurirani kako bi odražavali nova razvrstavanja tvari kao CMR na temelju Uredbe (EZ) br. 1272/2008, dio 3. Priloga VI. u potpunosti je izmijenjen uredbama Komisije (EU) br. 605/2014 [3], (EU) 2015/1221 [4] i (EU) 2016/1179 [5].
As operators may apply the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008 at an earlier date, they should be able to apply the provisions of this Regulation earlier, on a voluntary basis.
Budući da gospodarski subjekti mogu primjenjivati usklađeno razvrstavanje iz dijela 3. Priloga VI. Uredbi (EZ) br. 1272/2008 od ranijeg datuma, trebalo bi im omogućiti raniju provedbu odredaba ove Uredbe na dobrovoljnoj osnovi.
Regulation (EC) No 1907/2006 should be amended accordingly.
Uredbu (EZ) br. 1907/2006 stoga bi trebalo na odgovarajući način izmijeniti.
Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.
Prilog XVII. Uredbi (EZ) br. 1907/2006 mijenja se u skladu s Prilogom.
It shall apply from the date of entry into force, with the exception of:
Primjenjuje se od dana stupanja na snagu, uz iznimku:
paragraphs (1), (2) and (3) of the Annex, which shall apply on 1 March 2018, and
točaka 1., 2. i 3. Priloga, koje se primjenjuju od 1. ožujka 2018., i
paragraph (4)(a) of the Annex which shall apply on 1 March 2018 to the extent that it relates to the following substances:
točke 4. podtočke (a) Priloga, koja se primjenjuje od 1. ožujka 2018. u mjeri u kojoj se odnosi na sljedeće tvari:
bisphenol A; [phenol, dodecyl-, branched]; [phenol, 2-dodecyl-, branched]; [phenol, 3-dodecyl-, branched]; [phenol, 4-dodecyl-, branched]; [phenol, (tetrapropenyl) derivatives]; chlorophacinone (ISO); coumatetralyl (ISO); difenacoum (ISO); flocoumafen (ISO); disodium octaborate anhydrous; disodium octaborate tetrahydrate; bromadiolone (ISO); difethialone; [perfluorononan-1-oic acid, and its sodium and ammonium salts]; dicyclohexyl phthalate and triflumizole (ISO).
bisfenol A; [fenol, dodecil-, razgranani]; [fenol, 2-dodecil-, razgranani]; [fenol, 3-dodecil-, razgranani]; [fenol, 4-dodecil-, razgranani]; [fenol, (tetrapropenil) derivati]; klorofacinon (ISO); kumatetralil (ISO); difenakum (ISO); flokumafen (ISO); dinatrijev oktaborat, bezvodni; dinatrijev oktaborat tetrahidrat; bromadiolon (ISO); difetialon; [perfluorononan-1-oičnu kiselinu i njezine natrijeve i amonijeve soli]; dicikloheksil-ftalat i triflumizol (ISO).
Commission Regulation (EU) 2015/1221 of 24 July 2015 amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, for the purposes of its adaptation to technical and scientific progress (OJ L 197, 25.7.2015, p. 10).
Uredba Komisije (EU) 2015/1221 оd 24. srpnja 2015. o izmjeni Uredbe (EZ) br. 1272/2008 Europskog parlamenta i Vijeća o razvrstavanju, označivanju i pakiranju tvari i smjesa, za potrebe njezine prilagodbe tehničkom i znanstvenom napretku (SL L 197, 25.7.2015., str. 10.).
Commission Regulation (EU) 2016/1179 of 19 July 2016 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 195, 20.7.2016, p. 11).
Uredba Komisije (EU) 2016/1179 od 19. srpnja 2016. o izmjeni, u svrhu prilagodbe tehničkom i znanstvenom napretku, Uredbe (EZ) br. 1272/2008 Europskog parlamenta i Vijeća o razvrstavanju, označivanju i pakiranju tvari i smjesa za potrebe njezine prilagodbe tehničkom i znanstvenom napretku (SL L 195, 20.7.2016., str. 11.).
Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:
Prilog XVII. Uredbi (EZ) br. 1907/2006 mijenja se kako slijedi:
in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:
u Dodatku 2. sljedeći unosi umeću se u tablicu u skladu s utvrđenim redoslijedom indeks brojeva:
‘1,2-dichloropropane; propylene dichloride
„1,2-dikloropropan; propilen diklorid
e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).]
mikrovlakna e-stakla reprezentativnog sastava; [Vlakna od kalcij-aluminij-silikata proizvoljne orijentacije sa sljedećim reprezentativnim sastavom (maseni udio izražen u %): SiO2 50,0 – 56,0 %, Al2O3 13,0 – 16,0 %, B2O3 5,8 – 10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0 – 24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Postupak: tipično se proizvode atenuacijom plamena i rotacijskim procesom. (Dodatni pojedinačni elementi mogu biti prisutni u niskim postocima; postupak ne isključuje inovacije).]
in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:
u Dodatku 4. sljedeći unos umeće se u tablicu u skladu s utvrđenim redoslijedom indeks brojeva:
‘3,7-dimethylocta-2,6-dienenitrile
„3,7-dimetilokta-2,6-dienenitril
in Appendix 5,
u Dodatku 5.:
the following entries are inserted in the table in order of the index numbers set out therein:
sljedeći unosi umeću se u tablicu u skladu s utvrđenim redoslijedom indeks brojeva:
‘brodifacoum (ISO);
„brodifakum (ISO);
the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:
unos koji se odnosi na varfarin; 4-hidroksi-3-(3-okso-1-fenilbutil)kumarin zamjenjuje se sljedećim unosom:
‘warfarin (ISO);
„varfarin (ISO);
ydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1]
idroksi-3-(3-okso-1-fenilbutil)-2H-kromen-2-on; [1]
ydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2]
idroksi-3-(3-okso-1-fenilbutil)-2-benzopiron; [2]
ydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3]
idroksi-3-(3-okso-1-fenilbutil)-2-benzopiron [3]
in Appendix 6,
u Dodatku 6.:
‘tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol
„tetrahidro-2-furil-metanol; tetrathidrofurfuril alkohol
Tributyltin compounds, with the exception of those specified elsewhere in this Annex
tributilkositrovi spojevi, s iznimkom onih specificiranih drugdje u ovom Prilogu
1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear
1,2-benzendikarboksilna kiselina, diheksil-ester, razgranani i linearni
bisphenol A; 4,4′-isopropylidenediphenol
bisfenol A; 4,4′-izopropilidendifenol
phenol, dodecyl-, branched; [1]
fenol, dodecil-, razgranani; [1]
phenol, 2-dodecyl-, branched; [2]
fenol, 2-dodecil-, razgranani; [2]
phenol, 3-dodecyl-, branched; [3]
fenol, 3-dodecil-, razgranani; [3]
phenol, 4-dodecyl-, branched; [4]
fenol, 4-dodecil-, razgranani; [4]
chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione
klorofacinon (ISO); 2-[(4-klorofenil)(fenil)acetil]-1H-inden-1,3(2H)-dion
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
flokumafen (ISO); reakcijska smjesa: cis-4-hidroksi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluorometilbenziloksi)fenil)-1-naftil)kumarina i trans-4-hidroksi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluorometilbenziloksi)fenil)-1-naftil)kumarina
perfluorononan-1-oic acid [1]
perfluorononan-1-oična kiselina [1]
and its sodium [2]
i njezine natrijeve [2]
and ammonium [3] salts
i amonijeve [3] soli
the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:
unos koji se odnosi na flumioksazin (ISO); N-(7-fluoro-3,4-dihidro-3-okso-4-prop-2-inil)—2,H 1,4-benzoksazin-6-il) cikloheks-1-en-1,2dikarboksamid zamjenjuje se sljedećim unosom:
‘flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione
„flumioksazin (ISO); 2-[7-fluoro-3-okso-4-(prop-2-in-1-il)-3,4-dihidro-2H-1,4-benzoksazin-6-il]-4,5,6,7-tetrahidro-1H-izoindol-1,3 (2H)-dion
103361-09-7’
103361-09-7”
Commission Implementing Regulation (EU) 2017/1511
Provedbena uredba Komisije (EU) 2017/1511
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, cypermethrin, daminozide, deltamethrin, dimethenamid-p, flufenacet, flurtamone, forchlorfenuron, fosthiazate, indoxacarb, iprodione, MCPA, MCPB, silthiofam, thiophanate-methyl and tribenuron
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja razdoblja odobrenja aktivnih tvari 1-metil-ciklopropen, beta-ciflutrin, klorotalonil, klorotoluron, cipermetrin, daminozid, deltametrin, dimetenamid-p, flufenacet, flurtamon, forklorfenuron, fostiazat, indoksakarb, iprodion, MCPA, MCPB, siltiofam, tiofanat-metil i tribenuron
The approval periods of the active substances beta-cyfluthrin, deltamethrin, dimethenamid-p, flufenacet, flurtamone, fosthiazate, iprodione and silthiofam were last extended by Commission Implementing Regulation (EU) 2016/950 [3].
Rokovi valjanosti odobrenja za aktivne tvari beta-ciflutrin, deltametrin, dimetenamid-p, flufenacet, flurtamon, fostiazat, iprodion i siltiofam zadnji su put produljeni Provedbenom uredbom Komisije (EU) 2016/950 [3].
The approval periods of those substances will expire on 31 October 2017.
Rokovi valjanosti odobrenja za te tvari prestaju važiti 31. listopada 2017.
The approval periods of the active substances 1-methylcyclopropene, chlorothalonil, chlorotoluron, cypermethrin, daminozide, forchlorfenuron, indoxacarb, thiophanate-methyl, and tribenuron were extended by Commission Implementing Regulation (EU) No 533/2013 [4].
Rokovi valjanosti odobrenja za aktivne tvari 1-metil-ciklopropen, klorotalonil, klorotoluron, cipermetrin, daminozid, forklorfenuron, indoksakarb, tiofanat-metil i tribenuron produljeni su Provedbenom uredbom Komisije (EU) br. 533/2013 [4].
The approval periods of the active substances MCPA and MCPB were extended by Commission Implementing Regulation (EU) No 762/2013 [5].
Rokovi valjanosti odobrenja za aktivne tvari MCPA i MCPB produljeni su Provedbenom uredbom Komisije (EU) br. 762/2013 [5].
Applications for the renewal of the approval of the substances referred to in recitals 2, 3 and 4 were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 [6].
Zahtjevi za produljenje odobrenja za tvari iz uvodnih izjava 2., 3. i 4. podneseni su u skladu s Provedbenom uredbom Komisije (EU) br. 844/2012 [6].
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009 u slučajevima u kojima Komisija donosi uredbu kojom se predviđa da se odobrenje aktivne tvari iz Priloga ovoj Uredbi ne produljuje jer nisu ispunjena mjerila za odobrenje, Komisija kao datum isteka određuje isti datum koji je vrijedio prije donošenja te Uredbe ili datum stupanja na snagu uredbe kojom se predviđa da se odobrenje aktivne tvari ne produljuje, ovisno o tome koji je datum kasniji.
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
Stoga Provedbenu uredbu (EU) br. 540/2011 treba na odgovarajući način izmijeniti
Commission Implementing Regulation (EU) No 533/2013 of 10 June 2013 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methyl-cyclopropene, chlorothalonil, chlorotoluron, cypermethrin, daminozide, forchlorfenuron, indoxacarb, thiophanate-methyl and tribenuron (OJ L 159, 11.6.2013, p. 9).
Provedbena uredba Komisije (EU) br. 533/2013 od 10. lipnja 2013. o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenju razdoblja odobrenja aktivnih tvari 1-metil-ciklopropen, klorotalonil, klorotoluron, cipermetrin, daminozid, forklorfenuron, indoksakarb, tiofanat-metil i tribenuron (SL L 159, 11.6.2013., str. 9).
in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2018’;
u retku 40., za deltametrin, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2018’;
u retku 48., za beta-ciflutrin, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by ‘31 October 2018’;
u retku 50., za iprodion, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2018’;
u retku 64., za flurtamon, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2018’;
u retku 65., za flufenacet, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by ‘31 October 2018’;
u retku 67., za dimetenamid-p, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2018’;
u retku 69., za fostiazat, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by ‘31 October 2018’;
u retku 70., za siltiofam, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 101, Chlorothalonil, the date is replaced by ‘31 October 2018’;
u retku 101., za klortalonil, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2018’;
u retku 102., za klortoluron, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2018’;
u retku 103., za cipermetrin, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2018’;
u retku 104., za daminozid, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2018’;
u retku 105., za tiofanat-metil, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 106, Tribenuron, the date is replaced by ‘31 October 2018’;
u retku 106., za tribenuron, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2018’;
u retku 107., za MCPA, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2018’;
u retku 108., za MCPB, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 117, 1-methylcyclopropene, the date is replaced by ‘31 October 2018’;
u retku 117., za 1-metilciklopropen, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 118, Forchlorfenuron, the date is replaced by ‘31 October 2018’;
u retku 118., za forklorfenuron, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”;
in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2018’.
u retku 119., za indoksakarb, u šestom stupcu, „Prestanak odobrenja”, datum se zamjenjuje datumom „31. listopada 2018.”.
Commission Implementing Regulation (EU) 2017/1514
Provedbena uredba Komisije (EU) 2017/1514
initiating a review of Council Implementing Regulation (EU) No 1371/2013 (extending the definitive anti-dumping duty imposed by Implementing Regulation (EU) No 791/2011 on imports of certain open mesh fabrics of glass fibres originating in the People's Republic of China to imports of certain open mesh fabrics of glass fibres consigned from India and Indonesia, whether declared as originating in India and Indonesia or not) for the purposes of determining the possibility of granting an exemption from those measures to one Indian exporting producer, repealing the anti-dumping duty with regard to imports from that exporting producer and making imports from that exporting producer subject to registration
o pokretanju revizije Provedbene uredbe Vijeća (EU) br. 1371/2013 (o proširenju konačne antidampinške pristojbe uvedene Provedbenom uredbom (EU) br. 791/2011 na uvoz određenih tkanina otvorene mrežaste strukture od staklenih vlakana podrijetlom iz Narodne Republike Kine na uvoz određenih tkanina otvorene mrežaste strukture od staklenih vlakana poslanih iz Indije i Indonezije, bez obzira na to imaju li deklarirano podrijetlo iz Indije i Indonezije ili nemaju) radi utvrđivanja mogućnosti odobravanja izuzeća od tih mjera jednom indijskom proizvođaču izvozniku, stavljanja izvan snage antidampinške pristojbe s obzirom na uvoz od tog proizvođača izvoznika te nametanja obveze evidentiranja njegova uvoza
Having regard to Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union [1] (‘the basic Regulation’), in particular Articles 11(4), 13(4) and 14(5) thereof,
uzimajući u obzir Uredbu (EU) 2016/1036 Europskog parlamenta i Vijeća od 8. lipnja 2016. o zaštiti od dampinškog uvoza iz zemalja koje nisu članice Europske unije [1] („osnovna uredba”), a posebno njezin članak 11. stavak 4., članak 13. stavak 4. i članak 14. stavak 5.,
The European Commission (‘the Commission’) received a request for an exemption from the anti-dumping measures applicable to imports of certain open mesh fabrics of glass fibres originating in or consigned from the People's Republic of China as extended to imports of certain open mesh fabrics of glass fibres consigned from India and Indonesia, whether declared as originating in India and Indonesia or not, as far as the applicant is concerned, pursuant to Articles 11(4) and 13(4) of the basic Regulation.
Europska komisija („Komisija”) zaprimila je zahtjev za izuzeće od antidampinških mjera koje se primjenjuju na uvoz određenih tkanina otvorene mrežaste strukture od staklenih vlakana podrijetlom ili poslanih iz Narodne Republike Kine kako je proširen na uvoz određenih tkanina otvorene mrežaste strukture od staklenih vlakana poslanih iz Indije i Indonezije, bez obzira na to imaju li deklarirano podrijetlo iz Indije i Indonezije ili nemaju, u mjeri u kojoj se to odnosi na podnositelja zahtjeva, u skladu s člankom 11. stavkom 4. i člankom 13. stavkom 4. osnovne uredbe.
The request was lodged on 26 January 2017 by SPG GLASS FIBRE PVT.
Zahtjev je 26. siječnja 2017. predao SPG GLASS FIBRE PVT.
LTD (‘the applicant’), an exporting producer of certain open mesh fabrics of glass fibres in India (‘the country concerned’).
LTD. („podnositelj zahtjeva”), proizvođač izvoznik određenih tkanina otvorene mrežaste strukture od staklenih vlakana u Indiji („predmetna zemlja”).